Stock Analiz

Capstone Holding Corp. CAPS

Biotechnology: Pharmaceutical Preparations · data as of November 13, 2026

$1.74Market cap $2M
Open the interactive analysis →

Capstone Holding Corp. (CAPS) is a healthcare company listed in the US with a market value of about $2M. In the twelve months to September 30, 2026 it had revenue of $67M and net income of -$21M, a net margin of -31.1%.

Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is value (1/5); the weakest is future growth (0/5).

Key numbers: a 5-year average ROIC of 18%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 4176% above the current price.

About Capstone Holding

Capstone Holding is listed in the US and classified in biotechnology: pharmaceutical preparations. It was profitable in 2 of the last 10 years in our data. Its share count rose by 9685% over three years (dilution for shareholders).

Score: 0.6 / 5

Value1/5
Future growth0/5
Track record1/5
Financial health0/5
Shareholder returns1/5

Checks passed

  • Price below intrinsic value (DCF, moderate assumptions)
  • 5-year average ROIC above 12%
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.0
P/B0.1
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-208.3%
Shareholder yield0.0%
Intrinsic value vs. price+4176%

Growth and quality

Revenue growth (1 yr)2.3%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-19.6%
ROIC (5-yr avg.)18.2%
Profitable years (of last 10)2
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232018201720162015201420132012
Revenue$67M$47M$46M$48M———————
Net income-$21M-$21M-$3M-$4M$380000$2M-$663000-$3M-$4M-$4M-$4M
Free cash flow-$3M-$5M$4M$1M—————-$4M-$3M
EPS (diluted)$-23.36$-24.72$-209.22$-218.34$-0.06$-0.24$120.00$420.00$600.00$600.00$0.54
Net margin-31.1%-45.3%-5.6%-7.9%———————
ROIC—-28.4%-6.9%-6.9%12.9%120.2%—————

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 1 analysts is $7.50, 331% above the current price; targets range from $7.50 to $7.50; the consensus rating is “Strong buy”; expected EPS is $-1.50 for the fiscal year ending December 31, 2026.

Frequently asked questions

Is Capstone Holding stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 4176% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Capstone Holding pay a dividend?

Not currently.

Is Capstone Holding a good stock to buy?

We do not give buy or sell advice. Capstone Holding scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.